SLDB Earnings

Quarterly EPS
$-0.79
Q3 2024
$-1.00
Q4 2024
$-0.59
Q1 2025
$-0.42
Q2 2025
$-0.48
Q3 2025
$-0.52
Q4 2025
$-0.52
Q1 2026
$-0.38
Q2 2026
Latest RevenueN/A
Latest Net Income-54799000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.380-54799000+9.5%
Q1 2026-$0.520-56737000+11.9%
Q4 2025-$0.520-49787000+48.0%
Q3 2025-$0.480-45776000+39.2%
Q2 2025-$0.420-39480000+31.1%
Q1 2025-$0.590-39282000+7.8%
Q4 2024-$1.000-42597000+0.0%
Q3 2024-$0.790-32725000+24.8%
Q2 2024-$0.610-25072000
Q1 2024-$0.640-24303000
Q4 2023-$1.000-20336000
Q3 2023-$1.050-20980000
Solid Biosciences (SLDB) — Earnings